DeepCyte Launches World's First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance
Proprietary training dataset spanning 300,000 cells and ~100 compounds positions DeepCyte to transform preclinical toxicology with mechanism-based prediction WILMINGTON, Del. and COPENHAGEN, Denmark, Aug. 19, 2026 /PRNewswire/ -- DeepCyte Inc., a techbio comp…



